FDA approves Moderna’s mRNA-based vaccine for the flu

FDA approves Moderna’s mRNA-based vaccine for the flu

The shot, named mFlusiva, is intended for adults age 50 or older. Moderna said late Wednesday that it expects some of its new version to be available soon at select retailers.

The shot, named mFlusiva, is intended for adults age 50 or older. Moderna said late Wednesday that it expects some of its new version to be available soon at select retailers.
Lire l’article complet sur le site source
Global News (EN)




🤖

Assistant eFastWork

En ligne

📩 Envoyer un message à notre équipe


ou envoyez un message vocal
👋

Bienvenue !

Entrez votre email pour commencer à chatter.

Email utilisé uniquement pour vous répondre.